Cyclacel Pharmaceuticals, Inc.
CYCC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,212 | -$22,555 | -$21,198 | -$18,887 |
| Dep. & Amort. | $6 | $31 | $32 | $43 |
| Deferred Tax | $0 | $0 | $967 | $1,491 |
| Stock-Based Comp. | $592 | $1,473 | $1,506 | $1,157 |
| Change in WC | $2,661 | $5,008 | -$1,167 | -$853 |
| Other Non-Cash | -$37 | -$69 | -$967 | -$1,491 |
| Operating Cash Flow | -$7,990 | -$16,112 | -$20,827 | -$18,540 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$6 | -$7 | -$27 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$6 | -$7 | -$27 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,209 | $1,049 | $3,199 | $17,371 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$201 | -$201 | -$201 |
| Other Fin. Act. | $1,613 | $0 | $0 | $4,567 |
| Financing Cash Flow | $7,822 | $848 | $2,998 | $21,737 |
| Forex Effect | -$73 | $303 | -$378 | -$17 |
| Net Chg. in Cash | -$241 | -$14,967 | -$18,214 | $3,153 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,378 | $18,345 | $36,559 | $33,406 |
| End Cash | $3,137 | $3,378 | $18,345 | $36,559 |
| Free Cash Flow | -$7,990 | -$16,118 | -$20,834 | -$18,567 |